FDA Inspection 649158 — New York Blood Center, Inc.
The FDA completed an inspection of New York Blood Center, Inc. on February 4, 2010 in New Brunswick, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 4, 2010
- Fiscal Year
- 2010
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- New Brunswick, NJ (United States)